| Trial ID: | L7282 |
| Source ID: | NCT00790153
|
| Associated Drug: |
Insulin
|
| Title: |
To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Insulin|DRUG: AZD1656
|
| Outcome Measures: |
Primary: Pharmacodynamic variables, Blood samples taken repeatedly up to 6 hours during study days | Secondary: Pharmacokinetic variables, Blood samples taken repeatedly during 24 hours on study day sessions|Safety Variables (AEs, BP, pulse, electrocardiogram (ECG), hypoglycaemic symptoms and laboratory variables), Taken repeatedly during treatment periods
|
| Sponsor/Collaborators: |
Sponsor: AstraZeneca
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-11
|
| Completion Date: |
2009-02
|
| Results First Posted: |
|
| Last Update Posted: |
2009-04-10
|
| Locations: |
Research Site, Chula Vista, California, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00790153
|
